The genes that code for the transporters that are responsible for monoamine uptake were identified in the early 1990s. Monoamine transporters have been shown to be involved both in the regulation ...
Summary: Rasagiline is a novel, investigational propargylamine that irreversibly and selectively inhibits monoamine oxidase type B (MAO-B). Rasagiline demonstrates complete and selective ...
Monoamine oxidase inhibitors (MAOIs) were the first medications approved for the treatment of depression symptoms and are also used to treat several other medical conditions, such as Parkinson's ...
THE enzyme monoamine oxidase (monoamine : O 2 oxido-reductase (deaminating), EC 1.4.3.4) (MAO) is likely to be concerned in the metabolism of known or suspected central nervous system transmitters ...
Am J Health Syst Pharm. 2006;63(10):915-928. Results of this study suggest that adjunctive rasagiline significantly reduces off time with efficacy similar to that observed by adding entacapone to ...
Depression rates, which were already on the rise before the pandemic, appear to be higher than ever. One estimate from the World Health Organization (WHO) puts the global increase of people diagnosed ...
Together, the findings suggested that 17α-estradiol extensively reshaped the cell populations, cellular communication, neuropeptide secretion, and neural synapse activity in aged hypothalamus, which ...